Quantitative Outcomes for Shared Assessment and Management in Forensic Mental Health: A Meta-Analysis and Systematic Review.

Trauma Violence AbuseJun 26, 2025 (epub)
Clinical ResearchPsychiatry

Mimosa Luigi, Xavier Larochelle, Anne G Crocker

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined quantitative evidence on shared assessment and management among adult forensic mental health inpatients. Fifteen evaluations were included, although only one of three planned meta-analyses could be conducted. Across seven records with paired clinician–user ratings, the random-effects analysis found a significant, large paired standard difference of .95 (95% CI = [.49,1.42]). Clinicians generally rated patients as having more needs and making less progress than patients rated themselves. The review found an evidence gap on whether shared approaches improve care outcomes, including violence or restriction.

Key findings

  • Across seven records, clinician–user ratings showed a paired standard difference of .95 (95% CI = [.49,1.42]).
  • Clinicians generally rated more needs and less progress than users across assessment tools.
  • Quantitative evidence was insufficient to establish effects of shared approaches on violence or restriction.

Why it matters

Differences between clinician and user assessments may be clinically useful to identify divergent views of needs and progress and to prompt collaborative discussion in forensic settings. However, rating differences do not establish that shared assessment improves care outcomes. The review highlights the need for consistent agreement measures and stronger quantitative evaluation of outcomes.

What to keep in mind

Only one of three planned meta-analyses could be conducted, and the authors acknowledge between-study heterogeneity. Evidence on quantitative care outcomes remains limited.

Source

Published in Trauma Violence Abuse. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.